Comment
doi: 10.1053/jhep.2003.50213.
Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C
- PMID: 12830010
- DOI: 10.1053/jhep.2003.50213
Item in Clipboard
Comment
Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C
Hepatology.
2003 Jul.
No abstract available
Comment on
-
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.Hepatology. 2002 Nov;36(5):1273-9. doi: 10.1053/jhep.2002.36502. Hepatology. 2002. PMID: 12395340
Similar articles
-
[Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].Dtsch Med Wochenschr. 1999 May 21;124(20):636-42. doi: 10.1055/s-2007-1024379. Dtsch Med Wochenschr. 1999. PMID: 10370387 Review. German. No abstract available.
-
Combination therapy for chronic hepatitis C.Ital J Gastroenterol Hepatol. 1999 Mar;31(2):135-6. Ital J Gastroenterol Hepatol. 1999. PMID: 10363199 No abstract available.
-
[Ribavirin: a new drug in the treatment of chronic hepatitis C].Gastroenterol Hepatol. 1997 Aug-Sep;20(7):363-5. Gastroenterol Hepatol. 1997. PMID: 9377236 Review. Spanish. No abstract available.
-
[Treatment of chronic viral hepatitis].Ugeskr Laeger. 2008 Jun 9;170(24):2137-40. Ugeskr Laeger. 2008. PMID: 18565297 Danish.
-
Treatment of hepatitis C virus: the first decade.Semin Liver Dis. 2004;24 Suppl 2:19-24. doi: 10.1055/s-2004-832924. Semin Liver Dis. 2004. PMID: 15346242 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources